See a healthcare provider if you have side effects, if your symptoms get worse, or if you have questions about your treatment
When guided by a licensed provider, medical weight loss programs are designed with safety in mind
The current results show that number needed to benefit (NNTB) was 207 (95%CI: NNTB 129 to NNTB 620, Follow-up time: 3.48 1.51 years) for total MI, NNTB 67 (95%CI: NNTB 46 to NNTB 135, Follow-up time: 3.48 1.51 years) for MACE, NNTB 170 (95%CI: NNTB 120 to NNTB 306, Follow-up time: 3.48 1.51 years) for cardiovascular mortality, and NNTB 93 (95%CI: NNTB 52 to NNTB 1717, Follow-up time: 3.45 1.21 years) for coronary revascularization
Importantly, people who are pregnant, breastfeeding, under 18 years of age, or who have a current or previous eating disorder should not use weight loss supplements unless specifically advised to do so by a clinician
37 In a cohort study, Wium-Andersen and colleagues 34 found that GLP-1 RA use was associated with a lower risk of a subsequent alcohol-related event compared with DPP-4 inhibitor use both in the time period closest to initiation and after 1 year of follow-up
Your selection helps guide the provider review